Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors

Tenosynovial giant cell tumor (TSGCT) is a disease of disputed etiology and pathogenesis. Some investigations indicate a neoplastic origin of the tumors; others indicate that they are polyclonal and inflammatory. The cytogenetic and molecular genetic features of TSGCTs are largely unknown, as only s...

詳細記述

書誌詳細
出版年:Neoplasia: An International Journal for Oncology Research
主要な著者: Petter Brandal, Bodil Bjerkehagen, Sverre Heim
フォーマット: 論文
言語:英語
出版事項: Elsevier 2004-09-01
主題:
オンライン・アクセス:http://www.sciencedirect.com/science/article/pii/S1476558604800368
_version_ 1852740646504235008
author Petter Brandal
Bodil Bjerkehagen
Sverre Heim
author_facet Petter Brandal
Bodil Bjerkehagen
Sverre Heim
author_sort Petter Brandal
collection DOAJ
container_title Neoplasia: An International Journal for Oncology Research
description Tenosynovial giant cell tumor (TSGCT) is a disease of disputed etiology and pathogenesis. Some investigations indicate a neoplastic origin of the tumors; others indicate that they are polyclonal and inflammatory. The cytogenetic and molecular genetic features of TSGCTs are largely unknown, as only some 20 localized and 30 diffuse tumors with cytogenetic aberrations have been reported. The most common karyotypic aberrations have been trisomy for chromosomes 5 and 7 and translocations involving chromosomal area 1 pi 1-13. We decided to screen the genomes of TSGCTs by comparative genomic hybridization (CGH) to perform interphase fluorescence in situ hybridization (IP-FISH), looking for numerical aberrations of chromosomes 1, 5, and 7, and to analyze the tumors for microsatellite instability. Except for two diffuse TSGCTs that came fresh to us, and which, by karyotyping, exhibited t(1;22)(p13;g12) and a t(1;1)(g21;p11) and +7, respectively, all studies had to be performed on formalinfixed, paraffin-embedded material. DNA was extracted from 51 localized and nine diffuse TSGCTs. CGH was successful for 24 tumors, but none of them showed copy number changes. The IP-FISH studies showed trisomy 7 in 56% of the tumors (15/27), whereas chromosomes 1 and 5 seemed to be disomic in all TSGCTs. All informative tumors were wild-type by microsatellite instability analysis.
format Article
id doaj-art-a3a69f53db6d4828bdce9dc6e95ffb72
institution Directory of Open Access Journals
issn 1476-5586
1522-8002
language English
publishDate 2004-09-01
publisher Elsevier
record_format Article
spelling doaj-art-a3a69f53db6d4828bdce9dc6e95ffb722025-08-19T21:04:52ZengElsevierNeoplasia: An International Journal for Oncology Research1476-55861522-80022004-09-016557858310.1593/neo.04202Molecular Cytogenetic Characterization of Tenosynovial Giant Cell TumorsPetter Brandal0Bodil Bjerkehagen1Sverre Heim2Department of Cancer Genetics, The Norwegian Radium Hospital, Oslo, NorwayDepartment of Pathology, The Norwegian Radium Hospital, Oslo, NorwayDepartment of Cancer Genetics, The Norwegian Radium Hospital, Oslo, NorwayTenosynovial giant cell tumor (TSGCT) is a disease of disputed etiology and pathogenesis. Some investigations indicate a neoplastic origin of the tumors; others indicate that they are polyclonal and inflammatory. The cytogenetic and molecular genetic features of TSGCTs are largely unknown, as only some 20 localized and 30 diffuse tumors with cytogenetic aberrations have been reported. The most common karyotypic aberrations have been trisomy for chromosomes 5 and 7 and translocations involving chromosomal area 1 pi 1-13. We decided to screen the genomes of TSGCTs by comparative genomic hybridization (CGH) to perform interphase fluorescence in situ hybridization (IP-FISH), looking for numerical aberrations of chromosomes 1, 5, and 7, and to analyze the tumors for microsatellite instability. Except for two diffuse TSGCTs that came fresh to us, and which, by karyotyping, exhibited t(1;22)(p13;g12) and a t(1;1)(g21;p11) and +7, respectively, all studies had to be performed on formalinfixed, paraffin-embedded material. DNA was extracted from 51 localized and nine diffuse TSGCTs. CGH was successful for 24 tumors, but none of them showed copy number changes. The IP-FISH studies showed trisomy 7 in 56% of the tumors (15/27), whereas chromosomes 1 and 5 seemed to be disomic in all TSGCTs. All informative tumors were wild-type by microsatellite instability analysis.http://www.sciencedirect.com/science/article/pii/S1476558604800368CytogeneticsTSGCTtrisomy 7CGHsolid tumors
spellingShingle Petter Brandal
Bodil Bjerkehagen
Sverre Heim
Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
Cytogenetics
TSGCT
trisomy 7
CGH
solid tumors
title Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
title_full Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
title_fullStr Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
title_full_unstemmed Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
title_short Molecular Cytogenetic Characterization of Tenosynovial Giant Cell Tumors
title_sort molecular cytogenetic characterization of tenosynovial giant cell tumors
topic Cytogenetics
TSGCT
trisomy 7
CGH
solid tumors
url http://www.sciencedirect.com/science/article/pii/S1476558604800368
work_keys_str_mv AT petterbrandal molecularcytogeneticcharacterizationoftenosynovialgiantcelltumors
AT bodilbjerkehagen molecularcytogeneticcharacterizationoftenosynovialgiantcelltumors
AT sverreheim molecularcytogeneticcharacterizationoftenosynovialgiantcelltumors